Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Reprod Immunol ; 70(3): 230-7, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23611029

ABSTRACT

PROBLEM: Chronic histiocytic intervillositis (CHIV) is a rare type of placental pathology that is associated with reproductive loss at all gestational ages. The aim of the study was to investigate the relationship between the severity of CHIV and the outcome of pregnancy and to compare the immune response between CHIV patients and controls to explore an immunological origin of CHIV. METHOD OF STUDY: Microscopic slides were reviewed and scored according to a previously published grading system in 30 pregnancies of 22 CHIV patients. Partner-specific mixed lymphocyte reactions, cytotoxic T-lymphocyte precursor frequencies (CTLpf), and anti-HLA antibodies were determined in four patients and seven controls. RESULTS: Higher CHIV scores are associated with worse pregnancy outcome. CHIV patients demonstrated a higher CTLpf against their partner compared to non-complicated pregnancies (P = 0.03). The CTLpf was extremely high in 75% of the patients. Antipaternal HLA antibodies were only present in 75% of the CHIV patients compared to none of the controls (P = 0.02). CONCLUSION: CHIV scores seem to be associated with the severity of adverse pregnancy outcome. High antipaternal cellular (T-cell) and humoral (B-cell) response to partner-specific CTLpf and the presence of anti-HLA antibodies directed to the partner suggest an immunologic origin of CHIV.


Subject(s)
Abortion, Habitual/immunology , Chorionic Villi , Histiocytes , Placenta Diseases , Adult , B-Lymphocytes/immunology , Chorionic Villi/immunology , Chorionic Villi/metabolism , Chorionic Villi/pathology , Chronic Disease , Female , Gestational Age , HLA Antigens , Histiocytes/immunology , Histiocytes/pathology , Humans , Lymphocyte Culture Test, Mixed , Middle Aged , Placenta Diseases/immunology , Placenta Diseases/pathology , Pregnancy , Pregnancy Complications/immunology , Pregnancy Complications/pathology , Pregnancy Outcome , T-Lymphocytes, Cytotoxic/immunology , Young Adult
2.
Transplantation ; 83(11): 1485-92, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17565322

ABSTRACT

BACKGROUND: Interleukin (IL)-21 is the most recently described cytokine that signals via the common cytokine receptor (gammac), is produced by activated CD4+ T-cells, and regulates expansion and effector function of CD8+ T-cells. MATERIALS: To explore the actions of IL-21 with other gammac-dependent cytokines in alloreactivity, mRNA expression of IL-21, IL-21R alpha-chain, and IL-2 proliferation and cytotoxicity was measured after stimulation in mixed lymphocyte reactions. Additionally, IL-21 and IL-21R alpha-chain expression was studied in biopsies of heart transplant patients. RESULTS: Analysis of mRNA expression levels of allostimulated T-cells showed a 10-fold induction of IL-21 and IL-21R alpha-chain. Interestingly, induction of IL-21 was highly dependent on IL-2 (as in the presence of anti-IL-2, anti-IL-2R alpha-chain, and the immunosuppressive drugs cyclosporine A, tacrolimus, and rapamycin) the transcription of IL-21 was almost completely inhibited, whereas in the presence of exogenous IL-2 the mRNA expression of IL-21 was even more upregulated. IL-21 functioned as a costimulator for IL-2 to augment proliferation and cytotoxic responses, while blockade of the IL-2 route abrogated these functions of IL-21. Blockade of the IL-21 route by anti-IL-21R alpha-chain monoclonal antibodies inhibited the proliferation of alloactivated T-cells. Also, in vivo alloreactivity was associated with IL-21/IL-21R alpha-chain expression. After heart transplantation, the highest intragraft IL-21, IL-21R alpha-chain, and IL-2 mRNA expression levels were measured during acute rejection (P<0.001, P=0.01, P=0.03). CONCLUSION: IL-21 is a critical cytokine for IL-2 dependent immune processes. Blockade of the IL-21 pathway may provide a new perspective for the treatment of allogeneic responses in patients after transplantation.


Subject(s)
Graft Rejection/physiopathology , Heart Transplantation , Interleukin-2/metabolism , Interleukins/metabolism , Cell Proliferation , Cohort Studies , Cytotoxicity, Immunologic , Endocardium/metabolism , Graft Rejection/blood , Graft Rejection/genetics , Graft Rejection/metabolism , Humans , Immunosuppression Therapy , Interleukins/genetics , Lymphocyte Culture Test, Mixed , Myocardium/metabolism , Postoperative Period , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/metabolism , Receptors, Interleukin-21/genetics , Receptors, Interleukin-21/metabolism , T-Lymphocytes/pathology
SELECTION OF CITATIONS
SEARCH DETAIL